Tamara D. Cabalu

1.3k citations

17 papers · 449 · h-index 12

Impact in

Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Endocrine and Autonomic Systems top 10%
- Circadian rhythm and melatonin

Papers in

Cognitive Neuroscience 9
- Sleep and Wakefulness Research 9
Experimental and Cognitive Psychology 8
- Sleep and related disorders 8

Co-authors: Ka Lai Yee (5 shared papers)Donghui Cui (6 shared papers)Thomayant Prueksaritanont (6 shared papers)Christopher R. Gibson (2 shared papers)Jerome Hochman (1 shared paper)Xiaoyan Chu (1 shared paper)Jeanine Ballard (1 shared paper)Christopher J. Winrow (7 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (9 papers)The Journal of Clinical Pharmacology (2 papers)Toxicological Sciences (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)Xenobiotica (1 paper)
Partner nations: United States Germany Switzerland

In The Last Decade

Tamara D. Cabalu

17 papers receiving 442 citations

Peers

Countries citing papers authored by Tamara D. Cabalu

Since Specialization

Citations

This map shows the geographic impact of Tamara D. Cabalu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara D. Cabalu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara D. Cabalu more than expected).

Fields of papers citing papers by Tamara D. Cabalu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara D. Cabalu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara D. Cabalu. The network helps show where Tamara D. Cabalu may publish in the future.

Co-authors

The 25 scholars most cited alongside Tamara D. Cabalu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tamara D. Cabalu Line = papers co-authored together Tamara D. Cabalu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective The AAPS Journal ·Thomayant Prueksaritanont, Xiaoyan Chu, Christopher R. Gibson, Donghui Cui, Ka Lai Yee, Jeanine Ballard, Tamara D. Cabalu, Jerome Hochman	2013	195
2	Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model CPT Pharmacometrics & Systems Pharmacology ·Yuan Chen, Tamara D. Cabalu, Ernesto Callegari, Heidi J. Einolf, Lichuan Liu, Neil Parrott, Sheila Annie Peters, Edgar Schuck, Pradeep Sharma, Helen Tracey, Vijay Upreti, Ming Zheng, Andy Z. X. Zhu, Stephen D. Hall	2019	37
3	In vitro and in vivo characterisation of the metabolism and disposition of suvorexant in humans Xenobiotica ·Donghui Cui, Tamara D. Cabalu, Ka Lai Yee, James H. Small, Xiaodong Li, Bo Liu, Cheri M. Maciolek, Sheri Smith, Wen Liu, Jacqueline B. McCrea, Thomayant Prueksaritanont	2016	32
4	Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men Clinical Drug Investigation ·Ka Lai Yee, Jacqueline B. McCrea, Deborah Panebianco, Wen Liu, Nicole Lewis, Tamara D. Cabalu, Steven Ramael, Rebecca E. Wrishko	2018	23
5	Application of a Rat Liver Drug Bioactivation Transcriptional Response Assay Early in Drug Development That Informs Chemically Reactive Metabolite Formation and Potential for Drug-induced Liver Injury Toxicological Sciences ·James J Monroe, Keith Q. Tanis, Alexei A. Podtelezhnikov, Truyen Nguyen, Sam V. Machotka, Donna Lynch, Raymond Evers, Jairam Palamanda, Randy R. Miller, Todd R. Pippert, Tamara D. Cabalu, Timothy E. Johnson, Amy G. Aslamkhan, Wen Kang, Alex M. Tamburino, Kaushik Mitra, Nancy Agrawal, Frank D. Sistare	2020	22
6	Evaluation of Model‐Based Prediction of Pharmacokinetics in the Renal Impairment Population The Journal of Clinical Pharmacology ·Ka Lai Yee, Mengyao Li, Tamara D. Cabalu, Vaishali Sahasrabudhe, Jian Lin, Ping Zhao, Pravin Jadhav	2017	19
7	Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs) Bioorganic & Medicinal Chemistry Letters ·Swati P. Mercer, Anthony J. Roecker, Susan L. Garson, Duane R. Reiss, C. Meacham Harrell, Kathy Murphy, Joseph G. Bruno, Rodney A. Bednar, Wei Lemaire, Donghui Cui, Tamara D. Cabalu, Cuyue Tang, Thomayant Prueksaritanont, George D. Hartman, Steven D. Young, Christopher J. Winrow, John J. Renger, Paul J. Coleman	2013	19
8	Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant Bioorganic & Medicinal Chemistry Letters ·Izzat T. Raheem, Michael J. Breslin, Joseph G. Bruno, Tamara D. Cabalu, Andrew Cooke, Christopher D. Cox, Donghui Cui, Susan L. Garson, Anthony L. Gotter, Steven V. Fox, C. Meacham Harrell, Scott D. Kuduk, Wei Lemaire, Thomayant Prueksaritanont, John J. Renger, Craig A. Stump, Pamela L. Tannenbaum, Peter D. Williams, Christopher J. Winrow, Paul J. Coleman	2014	17
9	Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology Bioorganic & Medicinal Chemistry Letters ·Craig A. Stump, Andrew Cooke, Joseph G. Bruno, Tamara D. Cabalu, Anthony L. Gotter, C. Meacham Harell, Scott D. Kuduk, Terrence P. McDonald, Julie L. O'Brien, John J. Renger, Peter D. Williams, Christopher J. Winrow, Paul J. Coleman	2016	16
10	Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk, Jason W. Skudlarek, Christina N. DiMarco, Joseph G. Bruno, Mark H. Pausch, Julie A. O’Brien, Tamara D. Cabalu, Joanne Stevens, Joseph Brunner, Pamela L. Tannenbaum, Susan L. Garson, Alan T. Savitz, C. Meacham Harrell, Anthony L. Gotter, Christopher J. Winrow, John J. Renger, Paul J. Coleman	2015	15
11	Application of Physiologically Based Pharmacokinetic Modeling to Predict Pharmacokinetics in Healthy Japanese Subjects Clinical Pharmacology & Therapeutics ·Yuki Matsumoto, Tamara D. Cabalu, Punam Sandhu, Georgy Hartmann, Takashi Iwasa, Hiroyuki Yoshitsugu, Christopher R. Gibson, Naoto Uemura	2018	14
12	Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker, Swati P. Mercer, Jeffrey M. Bergman, Kevin F. Gilbert, Scott D. Kuduk, C. Meacham Harrell, Susan L. Garson, Steven V. Fox, Anthony L. Gotter, Pamela L. Tannenbaum, Thomayant Prueksaritanont, Tamara D. Cabalu, Donghui Cui, Wei Lemaire, Christopher J. Winrow, John J. Renger, Paul J. Coleman	2015	14
13	Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker, Swati P. Mercer, C. Meacham Harrell, Susan L. Garson, Steven V. Fox, Anthony L. Gotter, Thomayant Prueksaritanont, Tamara D. Cabalu, Donghui Cui, Wei Lemaire, Christopher J. Winrow, John J. Renger, Paul J. Coleman	2014	9
14	Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexant Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk, Jason W. Skudlarek, Christina N. Di Marco, Joseph G. Bruno, Mark Pausch, Julie A. O’Brien, Tamara D. Cabalu, Joanne Stevens, Joseph Brunner, Pamela L. Tannenbaum, Anthony L. Gotter, Christopher J. Winrow, John J. Renger, Paul J. Coleman	2014	7
15	Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin The Journal of Clinical Pharmacology ·Ka Lai Yee, Tamara D. Cabalu, Yuhsin Kuo, Kerry L. Fillgrove, Yang Liu, Ilias Triantafyllou, Sasha McClain, Daniel Dreyer, Larissa Wenning, S. Aubrey Stoch, Marian Iwamoto, Rosa I. Sánchez, Sauzanne Khalilieh	2020	5
16	Design, synthesis and SAR of substituted indoles as selective TrkA inhibitors Bioorganic & Medicinal Chemistry Letters ·Danielle M. Hurzy, Darrell A. Henze, Tamara D. Cabalu, Kartik Narayan, Amanda Heller, Andrew Cooke	2017	4
17	Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitors Bioorganic & Medicinal Chemistry Letters ·Gregori J. Morriello, Michael P. Dwyer, Yili Chen, Anthony T Ginetti, Shimin Xu, Jun Lu, Pravien Abeywickrema, Deping Wang, Alejandro Crespo, Tamara D. Cabalu, Jonathan E. Wilson, Shawn J. Stachel, Daniel V. Paone, Christopher J. Sinz	2021	1

About Tamara D. Cabalu

Tamara D. Cabalu is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology, Pharmacology, Endocrine and Autonomic Systems and Materials Chemistry, having authored 17 papers that have together received 449 indexed citations. Recurring topics across this work include Sleep and Wakefulness Research (9 papers), Sleep and related disorders (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Circadian rhythm and melatonin (4 papers), Photochromic and Fluorescence Chemistry (4 papers), Statistical Methods in Clinical Trials (3 papers), Chemical synthesis and alkaloids (2 papers) and Phosphodiesterase function and regulation (1 paper). The work is most often cited by research in Pharmacology (134 citations), Endocrine and Autonomic Systems (82 citations), Experimental and Cognitive Psychology (86 citations), Cognitive Neuroscience (120 citations) and Toxicology (16 citations). Tamara D. Cabalu has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Ka Lai Yee, Donghui Cui, Thomayant Prueksaritanont, Christopher R. Gibson, Jerome Hochman, Xiaoyan Chu, Jeanine Ballard, Christopher J. Winrow, Wen Liu and John J. Renger. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, The Journal of Clinical Pharmacology, Toxicological Sciences, CPT Pharmacometrics & Systems Pharmacology and Xenobiotica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Tamara D. Cabalu

Impact in

Papers in i

In The Last Decade

Tamara D. Cabalu

Peers

Countries citing papers authored by Tamara D. Cabalu

Fields of papers citing papers by Tamara D. Cabalu

All Works

About Tamara D. Cabalu

Explore authors with similar magnitude of impact

Papers in